Evaluation of MCT1, MCT4 and CD147 Genes in Peripheral Blood Cells of Breast Cancer Patients and Their Potential Use as Diagnostic and Prognostic Markers

Author： Luz Maria Cláudia de B.   Perez Matheus M.   Azzalis Ligia A.   Sousa Luiz Vinícius de A.   Adami Fernando   Fonseca Fernando L. A.   Alves Beatriz da C. A.  

Publisher： MDPI

E-ISSN： 1422-0067|18|4|170-170

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.18, Iss.4, 2017-03, pp. : 170-170

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Background: Patients with breast cancer—the deadliest cancer among women—are at constant risk of developing metastasis. Oxidative stress and hypoxia are common feature of tumor cells that can proliferate even in a resultant metabolic acidosis. Despite the low extracellular pH, intracellular pH of tumor cells remains relatively normal, or even more alkaline due to the action of a membrane protein family known as monocarboxylate transporters (MCTs). The objective of this study was to verify the diagnostic and prognostic value of MCT1, MCT4 and CD147 in tumor and peripheral blood samples of patients with breast cancer undergoing chemotherapic treatment. Methods: Differential expression of MCT1, MCT4 and CD147 obtained by qPCR was determined by 2−ΔΔCq method between biological samples (tumor and serial samples of peripheral) of patients (n = 125) and healthy women (n = 25). Results: tumor samples with higher histological grades have shown higher expression of these markers; this higher expression was also observed in blood samples obtained at diagnosis of patients when compared to healthy women and in patients with positive progression of the disease (metastasis development). Conclusion: markers studied here could be a promising strategy in routine laboratory evaluations as breast cancer diagnosis and prognosis.

Related content

Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals

By Cao Xue   Tang Qiuqiong   Holland-Letz Tim   Gündert Melanie   Cuk Katarina   Schott Sarah   Heil Jörg   Golatta Michael   Sohn Christof   Schneeweiss Andreas   Burwinkel Barbara  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 900-900 (1)

MDPI

Access to resources Recommend Favorite

Detection of Tumor Cell-Specific mRNA in the Peripheral Blood of Patients with Breast Cancer—Evaluation of Several Markers with Real-Time Reverse Transcription-PCR

By Andergassen Ulrich   Hofmann Simone   Kölbl Alexandra C.   Schindlbeck Christian   Neugebauer Julia   Hutter Stefan   Engelstädter Verena   Ilmer Matthias   Friese Klaus   Jeschke Udo  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 1093-1104 (12)

MDPI

Access to resources Recommend Favorite

Activation of VCAM-1 and Its Associated Molecule CD44 Leads to Increased Malignant Potential of Breast Cancer Cells

By Wang Pei-Chen   Weng Ching-Chieh   Hou You-Syuan   Jian Shu-Fang   Fang Kuan-Te   Hou Ming-Feng   Cheng Kuang-Hung  

International Journal of Molecular Sciences, Vol. 15, Iss. 3, 2014-02 ,pp. : 3560-3579 (20)

MDPI

Access to resources Recommend Favorite

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †

By Schulz Heiko   Schmoeckel Elisa   Kuhn Christina   Hofmann Simone   Mayr Doris   Mahner Sven   Jeschke Udo  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1230-1230 (1)

MDPI

Access to resources Recommend Favorite

Expression of Human Endogenous Retrovirus env Genes in the Blood of Breast Cancer Patients

By Rhyu Dong-Won   Kang Yun-Jeong   Ock Mee-Sun   Eo Jung-Woo   Choi Yung-Hyun   Kim Wun-Jae   Leem Sun-Hee   Yi Joo-Mi   Kim Heui-Soo   Cha Hee-Jae  

International Journal of Molecular Sciences, Vol. 15, Iss. 6, 2014-05 ,pp. : 9173-9183 (11)

MDPI

Access to resources Recommend Favorite